HPV Test Misses Twice as Many Women Who Develop Cervical Cancer as Cotesting, Quest Diagnostics Health Trends™ Study Finds
The largest study of a nationally representative American population demonstrates co-testing outperforms HPV or Pap testing alone in detecting cancer and precancer in women 30 years and older. The study is significant because it is the largest to date to assess the performance of guideline-recommended cervical cancer screening methods in a diverse population of American women in real-world care settings. It reveals stark differences in the performance of the various recommended methods in detecting cancer and precancers in women 30 years of age and older.
Eko Appoints Bryan Humbarger to the Position of Senior Vice President, Commercial
Mr. Humbarger will oversee sales and commercial operations for Eko’s AI and telemedicine software platforms for health systems, practices and providers worldwide.
With Second Mevion Proton System Installed at Siteman Cancer Center, Additional Cancer Patients Begin Treatment
The newest addition to the S. Lee Kling Proton Therapy Center features Mevion’s industry-leading HYPERSCAN® technology and Adaptive Aperture® pMLC. HYPERSCAN provides faster and more precise targeted dose delivery to tumors and minimizes the damage to surrounding healthy tissue and sensitive organs at risk.
Hologic Launches its First Cart-Based Ultrasound System, SuperSonic™ MACH 40
SuperSonic MACH 40 system leverages exclusive UltraFast™ imaging technology, inspired by cutting-edge graphics innovations from the video gaming industry, to provide greater frame rates of up to 20,000 images per second.
Balt Receives CE Mark and Performs First-in-Man for the Silk Vista Flow Diverter Stent
Balt introduced the Flow Diverter Stent two years ago, a first-in-class flow diverter device for the treatment of distal aneurysms with the benefits of excellent visibility and device deployment.